Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin prophylaxis during azacitidine treatment for myelodysplastic syndrome
MOH_2017-06-13_000478Phase 3Not yet recruiting
- Sponsor
- ד"ר דרורית מרקל. מדובר במחקר חוקרים
- Start
- Apr 2016
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bacterial disease and myelodysplastic syndrome (MDS) comparing Levofloxacin prophylaxis plus azacitidine with Placebo plus azacitidine (2 arms). Planned start Apr 2016; status: not yet recruiting.
02
Drugs
levofloxacinazacitidine
03
Conditions
bacterial diseasemyelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on MOH_2017-06-13_000478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2017-06-13_000478.